| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PHARMASIMPLE Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 1,200 | +3,45 % | Innocan Pharma Corporation: Was der Online-Start auslöst | ||
| SYNBIOTIC | 0,801 | -5,76 % | Viome Acquires Solaria Bio To Expand Into Clinically Validated Synbiotics And Medical Foods | ||
| BIONANO GENOMICS | 1,440 | +0,35 % | Bionano Genomics: Bionano Announces Hiring of Chief Scientific Officer | SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 151,75 | +0,90 % | Axsome Therapeutics, Inc.: Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2 | ||
| JAGUAR HEALTH | 4,795 | +0,10 % | Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi | Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| TRULIEVE CANNABIS | 9,419 | -1,13 % | Trulieve Lower on Repaying Notes | ||
| WEST PHARMACEUTICAL SERVICES | 322,40 | -1,38 % | What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report | ||
| SHIONOGI | 15,920 | +1,56 % | Fierce Pharma Asia-Novartis' $7.8B mRNA deal; Shionogi's $2B buy; ArriVent's phase 3 flop | ||
| KALA BIO | 0,294 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -4- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS1509643029 CENNTRO... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,220 | +2,51 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| CHARLOTTES WEB | 0,224 | +12,00 % | Charlotte's Web Holdings, Inc.: Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future | Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in hemp wellness, and Edibles.com, a premier retailer and online... ► Artikel lesen | |
| NRX PHARMACEUTICALS | 2,525 | -0,59 % | NRX Pharmaceuticals, Inc. - 8-K, Current Report | ||
| MIRUM PHARMACEUTICALS | 76,74 | +8,73 % | Mirum Pharmaceuticals, Inc.: Mirum Pharmaceuticals gibt bekannt, dass der primäre Endpunkt in der Phase-3-Studie AZURE-1 zu Brelovitug bei chronischer Hepatitis-Delta-Virus-Infektion erreicht wurde | - Der primäre Endpunkt der Phase-3-Studie (virologisches Ansprechen und Normalisierung der ALT-Werte) wurde in beiden Dosierungsgruppen in Woche 24 erreicht - Daten nach 48 Wochen aus dem Phase-2b-Teil... ► Artikel lesen | |
| BEXIMCO PHARMACEUTICALS | 0,630 | 0,00 % | Beximco Pharmaceuticals settles dispute with Bangladesh regulator |